HomeNewsBusinessStocksHere are SP Tulsian's top trading ideas

Here are SP Tulsian's top trading ideas

In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.

September 12, 2017 / 16:11 IST
Story continues below Advertisement

Your browser doesn't support HTML5 video.

In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.

Below is the verbatim transcript of the interview.

Story continues below Advertisement

Anuj: Thoughts on Divis Laboratories. It is a stock which was a huge multi-bagger and then we had all these problems with the US Food and Drug Administration (FDA). Do you get a sense that the risk reward is favourable? What have you made of this 10 percent move today?

A: Maybe 10 percent upmove is justified mainly for two reasons. One on the fundamental reason of the remediation of the both units seen happening, unit one and two. And if you really see, the stock was underowned and quite short-sold and probably the short covering and also may have led to the 10 percent rise because if you really take a call amongst the pharma stocks, you have to be very selective. You just cannot generalise and take a renewed buying call on all the stocks.